Time until relapse in tuberculosis treatment trials: implication for phase 3 trial design

Am J Respir Crit Care Med. 2012 Sep 1;186(5):464. doi: 10.1164/ajrccm.186.5.464.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antitubercular Agents / therapeutic use*
  • Clinical Trials, Phase III as Topic / methods*
  • Follow-Up Studies
  • Humans
  • Recurrence
  • Time Factors
  • Treatment Outcome
  • Tuberculosis / drug therapy*

Substances

  • Antitubercular Agents